KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent Deferred Tax AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Work In Process (2016 - 2019)

Pfizer has reported Work In Process over the past 11 years, most recently at $5.2 billion for Q1 2019.

  • Quarterly Work In Process rose 15.54% to $5.2 billion in Q1 2019 from the year-ago period, while the trailing twelve-month figure was $5.2 billion through Mar 2019, up 15.54% year-over-year, with the annual reading at $4.7 billion for FY2018, 20.29% up from the prior year.
  • Work In Process was $5.2 billion for Q1 2019 at Pfizer, up from $4.7 billion in the prior quarter.
  • Over five years, Work In Process peaked at $5.2 billion in Q1 2019 and troughed at $3.4 billion in Q1 2015.
  • The 5-year median for Work In Process is $4.0 billion (2016), against an average of $4.2 billion.
  • Year-over-year, Work In Process increased 21.06% in 2015 and then dropped 6.0% in 2016.
  • A 5-year view of Work In Process shows it stood at $3.9 billion in 2015, then dropped by 6.0% to $3.7 billion in 2016, then grew by 5.74% to $3.9 billion in 2017, then rose by 20.29% to $4.7 billion in 2018, then grew by 10.23% to $5.2 billion in 2019.
  • Per Business Quant, the three most recent readings for PFE's Work In Process are $5.2 billion (Q1 2019), $4.7 billion (Q4 2018), and $4.8 billion (Q3 2018).